Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04537312

Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM)

This is a pilot study to determine safety, efficacy, and potential risks of robot assisted nipple sparing mastectomy (RNSM), by utilizing the daVinci surgical system.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

About this study

With the advances of breast reconstruction after mastectomy for the treatment of breast diseases including breast cancer, surgical techniques have evolved to preserve the skin flaps and nipple areolar complex (NAC) to give better aesthetic outcome without compromising outcome. Mastectomy that preserves the NAC is called nipple sparing mastectomy (NSM). NSM can provide major psychosocial benefits for patients but is technically demanding and challenging to perform. Total mammary glandular excision in NSM can be technically challenging due to small size of the incision and poor visualization of dissection plane. Recent studies demonstrate feasibility and safety of performing minimally invasive robot-assisted NSM (RNSM). The technique of RNSM is still novel.

This is a single-arm pilot study for feasibility and safety of RNSM.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Surgical candidates, per standard of care for:
  • Nipple sparing resection and reconstruction OR
  • Prophylactic mastectomy for risk reduction mastectomy OR
  • Treatment of ductal carcinoma in-situ or clinically node negative cT1-T3 breast cancer
  • Surgical candidates for open NSM, per standard of care, with regards to patient anatomic factors and tumor location
  • Patient has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1

Exclusion criteria

  • Pregnant or nursing women
  • Patients with:
  • Inflammatory breast cancer
  • Skin involvement with tumor
  • Pre-operative diagnosis (radiological or pathologic) of nipple-areola complex involvement with tumor
  • Grade 3 ptosis of nipple
  • Smokers with heavy current use of nicotine (defined as > 20 cigarettes/day)
  • Patients that are high risk for anesthesia, as documented in medical record
  • Patients that do not have the ability to give informed consent
  • Prisoner status at surgical clinic visit
  • Bra cup size greater than C cup
  • Previous thoracic radiation history (for any reason)

Treatment and study plan

Robot-assisted Nipple Sparing Mastectomy

Procedure

Under RNSM

Survey Administration

Other

ancillary correlative

RNSM

Device

Robot-assisted Nipple Sparing Mastectomy

Primary outcomes

  1. Feasibility of removal of breast gland en bloc through RNSM

    Time frame: Up to 1 year

    Measure number of patients who had breast removed en bloc through RNSM incision.

  2. Complication rate of patients with bleeding requiring re-operation

    Time frame: Up to 1 year

    Number of patients with bleeding requiring re-operation after RNSM.

  3. Complication rate of patients with infection requiring antibiotics or re-operation

    Time frame: Up to 1 year

    Number of patients with infection after surgery requiring antibiotics or re-operation.

  4. Complication rate of patients with Mastectomy flap (SKIN flap score)

    Time frame: Up to 1 year

    Number of patients with mastectomy flap or nipple-areolar complex necrosis as measured using the SKIN flap score after surgery. Score of A1 indicates normal skin, D4 indicates total full thickness necrosis.

  5. Perioperative Outcomes investigating the total duration of surgical time

    Time frame: Up to 1 year

    Investigate the total duration of the operation (surgical time data),

  6. Perioperative Outcomes investigating length of surgery time

    Time frame: Up to 1 year

    Investigate the total duration of the operation (surgical time data) of each patient

  7. Perioperative Outcomes investigating the length of hospitalization

    Time frame: Up to 1 year

    Investigate the length of hospitalization for each patient

Secondary outcomes

  1. Surgeon musculoskeletal fatigue with RNSM using (SURG-TLX) survey

    Time frame: Up to 1 year

    Surgery Task Load Index (SURG-TLX) survey from each surgeon performing surgery.

  2. Surgeon musculoskeletal fatigue with RNSM using NMSQ questionnaire

    Time frame: Up to 1 year

    Musculo-Skeletal Questionnaire (NMSQ) from each surgeon performing surgery.

  3. Patient Reported Outcomes

    Time frame: Up to 1 year

    Monofilament testing to test for sensation recovery after surgery from each participant. Semmes Weinstein monofilament exam; sensation to series of monofilament with different thickness, compare sensation to preoperative exam.

  4. Patient Reported Outcomes

    Time frame: Up to 1 year

    Patient satisfaction with the breast after surgery measured by BREAST-Q survey. Lowest score = 0, highest = 100 with higher scores indicating better outcomes / quality of life.

Sponsors and collaborators

Lead sponsor

Ohio State University Comprehensive Cancer Center

Other

Registry information

Important dates

Study start
2020
Primary completion
2025
Study completion
2026
First posted
Sep 3, 2020
Registry last updated
Dec 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.